Risks of the Drugs Assessment Process in the Slovak Republic

The analysis confirmed that there were significant risks in the process of drug assessment in the period 2017 to 2020 in Slovakia and this process was not optimally set.

 

• Summary of the Analysis in English HERE (pdf, 0,2 MB)
• Full Analysis in Slovak language can be found HERE (pdf, 0,5 MB)